Alacrimia-choreoathetosis-liver dysfunction syndrome Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

2Recruiting trials

🩺

2Specialists

Regulatory Watchboard

2 events

Jan 2025A Study of GlcNAc on Tear Production in NGLY1-CDDG

Eva Morava-Kozicz — PHASE2

TrialACTIVE NOT RECRUITING

Feb 2024Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency

Grace Science, LLC — PHASE1, PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Alacrimia-choreoathetosis-liver dysfunction syndrome.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials

1Phase 2

1PHASE1, PHASE2

2Total recruiting

Search clinical trials for Alacrimia-choreoathetosis-liver dysfunction syndrome →

Recent News & Research

No recent news articles indexed yet for Alacrimia-choreoathetosis-liver dysfunction syndrome.
Search PubMed for Alacrimia-choreoathetosis-liver dysfunction syndrome →

Browse all Alacrimia-choreoathetosis-liver dysfunction syndrome news →

Specialist Network

Top 2 by expertise

Eva Morava-Kozicz, MD, PhD, M.D

Icahn School of Medicine at Mount Sinai

📍 ROCHESTER, MN

Score 117 trials

Bernhard Suter, MD, M.D

Baylor College of Medicine

📍 HOUSTON, TX

Score 21 trial

View all Alacrimia-choreoathetosis-liver dysfunction syndrome specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰